Importantly, this combination approach regulates protein levels of MMP-2 and MMP-9 via TNF-α/AKT/NF-κB axis to impair metastasis of HPV-positive HNSCC and HPV-negative HSNCC cells. The gene discussed is MMP2; the disease is head and neck squamous cell carcinoma.